NanoPsy Inc. Closes Seed Round, Funds to Be Used to Prove Efficacy of Nanobowl Technology with Ketamine and LSD

Toronto, Ontario--(Newsfile Corp. - June 29, 2021) - NanoPsy Inc., a company that develops nanotechnology for theranostic applications to effectively improve psychedelic drug efficacy, has announced the completion of its seed financing round. The company has raised C$500,000 in equity at C$4.1mm post money valuation.NanoPsy is being advised by capital market consultants Terrella Capital Corp. and LACG Capital Inc. Participating investors include Negev Capital, a psychedelic medical...

2021-06-29 7:30 AM EDT